Hematology/ Oncology and Stem Cell Therapy

SJR Rank #11,764H-index: 34SJR: 0.506Best quartile: Q3Open AccessListed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Wolters Kluwer Health

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.150.30.450.6

Subject Categories

  • HematologyQ3
  • Medicine (miscellaneous)Q3
  • OncologyQ3

Areas: Medicine

Most published research topics

Hematopoietic Stem Cell TransplantationAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia researchHemoglobinopathies and Related DisordersChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsMultiple Myeloma Research and TreatmentsMyeloproliferative Neoplasms: Diagnosis and TreatmentCAR-T cell therapy research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03570105140

Documents per Year

20222025036912

Detailed Information

ISSN

2589-0646, 1658-3876

SJR Best Quartile

Q3

Region

Western Europe

Citations per Document (2 years)

1.32

References per Document

12.00

Coverage

2008-2025

Scope

Hematology Oncology and Stem Cell Therapy is an international, peer-reviewed, open access journal that provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology. The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors.The journal prioritizes publication of original research articles but also would give consideration for brief reports, review articles, special communications, and unique case reports. It also offers a special section for clinically relevant images that provide an important educational value.

Metrics from SCImago Journal Rank 2025. View on SCImago